PROCTER & GAMBLE HEALTH L Stock Context for AI Screening

PROCTER & GAMBLE HEALTH L is a small-cap stock in Healthcare. This page summarizes key screening signals for PROCTER & GAMBLE HEALTH L, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.

Open interactive PGHL stock page

Price

₹6,108.50

1W return

+8.07%

1M return

+17.09%

3M return

+22.47%

6M return

+4.72%

1Y return

+6.24%

Market cap

₹10,139.74 cr

31.02

19.33

ROE

+50.72%

ROCE

+68.73%

RSI

71.55

Turnover

₹8.51 cr

Why it can matter in screens

Momentum: PGHL is above 50DMA, above 200DMA; RSI is 71.55.
Returns: 1D +1.29%, 1W +8.07%, 1M +17.09%, 3M +22.47%, 1Y +6.24%.
Trend levels: 52W high ₹6,581.50, 52W low ₹4,778.60, off high -7.19%.
Liquidity: latest turnover is ₹8.51 cr; volume vs 20D is +0.31%.
Valuation/profitability: PE 31.02, PB 19.33, ROE +50.72%, ROCE +68.73%.
Growth: 3Y sales CAGR +4.46%, 3Y profit CAGR +4.36%.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	370.45 cr	139.59 cr	94.60 cr	56.99
2025-12-31	373.86 cr	114.82 cr	77.59 cr	46.74
2025-09-30	324.92 cr	125.22 cr	88.54 cr	53.54
2025-06-30	338.74 cr	94.37 cr	66.18 cr	39.87
2025-03-31	310.99 cr	84.03 cr	61.18 cr	36.86
2024-12-31	309.77 cr	127.39 cr	n/a	nan
2024-09-30	313.41 cr	117.32 cr	n/a	nan
2024-06-30	262.11 cr	30.19 cr	16.78 cr	nan

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2024-06-30	1,129.49 cr	301.44 cr	200.98 cr	121.00
2023-06-30	1,205.86 cr	343.07 cr	229.47 cr	138.00
2022-06-30	1,114.41 cr	280.87 cr	192.52 cr	115.98
2021-06-30	990.79 cr	264.12 cr	176.80 cr	107.00

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	841.35 cr	177.24 cr	9.29 cr	524.55 cr
2025-09-30	894.40 cr	279.30 cr	6.20 cr	619.73 cr
2025-03-31	794.20 cr	182.08 cr	7.62 cr	536.96 cr
2024-12-31	870.15 cr	266.43 cr	8.28 cr	610.46 cr
2024-06-30	794.36 cr	238.50 cr	9.56 cr	538.24 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	n/a	n/a	n/a
2025-12-31	n/a	n/a	n/a
2025-09-30	n/a	n/a	n/a
2025-06-30	n/a	n/a	n/a
2025-03-31	49.22 cr	45.99 cr	n/a

Shareholding Trend

Period	Promoter	FII/FPI	DII	MF	Retail	Pledge
2026-03-31	+51.82%	+6.20%	+13.67%	+10.20%	+28.31%	+0.00%
2025-12-31	+51.82%	+6.97%	+13.84%	+10.48%	+27.37%	+0.00%
2025-09-30	+51.82%	+7.24%	+13.91%	+10.56%	+27.04%	+0.00%
2025-06-30	+51.82%	+6.99%	+14.16%	+10.65%	+27.03%	+0.00%
2025-03-31	+51.82%	+6.87%	+14.21%	+10.54%	+27.11%	+0.00%

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	429,121.06 cr	40.824543	+15.06%	+7.26%
DIVISLAB	DIVI S LABORATORIES LTD	174,585.42 cr	68.707369	+17.81%	+0.71%
TORNTPHARM	TORRENT PHARMACEUTICALS L	147,849.87 cr	68.354079	+29.94%	+39.35%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	119,204.71 cr	64.295958	+23.21%	+21.70%
CIPLA	CIPLA LTD	111,088.72 cr	29.624450	+12.91%	-6.65%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	108,331.15 cr	21.874917	+20.44%	+16.21%
DRREDDY	DR. REDDY S LABORATORIES	105,181.70 cr	24.542479	+13.88%	+1.20%
LUPIN	LUPIN LIMITED	103,385.66 cr	22.341869	+29.22%	+15.72%

Try these prompts

Analyze PROCTER & GAMBLE HEALTH L with valuation, momentum and industry peers
Compare PGHL with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-06-03. Not investment advice.